Making More Health Accelerator 2023
Social and Business Co-Creation, Fostering win-win collaborations
Focus areas
The accelerator broadly focuses on supporting social entrepreneurs with innovative solutions aimed at advancing access to healthcare in Sub-Saharan Africa. Solutions may be both in the animal or human health field. The specific countries from which we are currently selecting participants are Kenya, Uganda, Rwanda, Nigeria, and Ghana.
Program criteria
You should apply for the program if you have an innovative human or animal health solution that fits the description provided above and if you meet the criteria below.
Legal Entity: Company limited by guarantee, Limited liability company, NGO
Age: At least three years of operation
Sector: Human or animal health related.
Country of operation: Ghana, Nigeria, Kenya, Uganda, and Rwanda.
Revenue: At least USD 100K in annual sales revenue.
Impact: Evidence of social impact with clearly defined impact metrics
Benefits
Knowledge Access:
The program offers participants multiple opportunities for professional growth and development in their entrepreneurial journey. Includes in-person and online workshops and seminars on topics about operations, systems change, replication and transfer, social finance, among others.
Technical expertise:
Participants have access to experienced employees at Boehringer Ingelheim who volunteer their time to provide hands-on technical support across a variety of professional disciplines. Engagement with BI employees may take place virtually or in-person through an Executive in Residence program that has experienced executives placed within the social entrepreneurs’ organizations for between 2-4 weeks to work on specific aspects of the projects. Additionally, the program engages a number of consultants to offer tailored expert support to participants in areas such as investor engagement, communications and pitching.
Strategic networks:
Accelerator participants become part of an ever growing and closely knit community of ecosystem actors including impact investors, foundations, philanthropists, government agencies, corporate executives, social entrepreneurs, experts and multinational healthcare companies all committed to improving health care access for humans and animals across Africa. Successful applicants will also be able to tap into the newly launched Making More Health access network that will potentially leverage the expert engagement and support between the social entrepreneurs and the Boehringer Ingelheim employees.
Financial and Investor access support
The program provides each participant with a grant of 50k Euro for pilot implementation, with the possibility of additional scale up funds at the end of a successful pilot. Participants also receive expert-led investment readiness coaching and support before and after the program to facilitate access to third party investors. In addition, the program gives program participants a platform to showcase their innovations and engage a growing community of impact investors at MMH’s annual investor showcase event as well as other external investor access events. Additionally, entrants into the business accelerator community will have opportunities to apply for extra funding via the just launched Boehringer Ingelheim Social Engagement Fund.
(adsbygoogle = window.adsbygoogle || []).push({}); (adsbygoogle = window.adsbygoogle || []).push({});Business Collaboration
Where there is a timely and strategic fit between Boehringer Ingelheim and an accelerator participant, there is the potential for a strategic business collaboration to be formed with the promise of significant long-term benefits for both organizations.
Source : https://vc4a.com/ashoka/mmh-2023/
